What is a stock summary page? Click here for an overview.
Business Description
Marizyme Inc
NAICS : 325412
SIC : 2834
ISIN : US5703721028
Description
Marizyme Inc is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical device technologies that improve patient health outcomes. Currently, the company is focused on developing three medical technology products: DuraGraft, Krillase, and MATLOC. DuraGraft is a single-use intraoperative vascular graft treatment that protects against ischemic injury and reduces the incidence and complications of graft failure, MATLOC is a point-of-care, lab-on-chip digital screening, and diagnostic device platform, initially being developed for quantitative chronic kidney disease, or CKD, assessment, and Krillase protein enzyme provides a therapeutics opportunity for wound healing, thrombosis, and pet health.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -0.73 | |||||
| Debt-to-Equity | -1.72 | |||||
| Debt-to-EBITDA | -5.51 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -13.73 | |||||
| Beneish M-Score | -7.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 26 | |||||
| 3-Year EBITDA Growth Rate | -83.6 | |||||
| 3-Year EPS without NRI Growth Rate | -58.7 | |||||
| 3-Year FCF Growth Rate | 7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.93 | |||||
| 9-Day RSI | 23.89 | |||||
| 14-Day RSI | 22.1 | |||||
| 3-1 Month Momentum % | 212.5 | |||||
| 6-1 Month Momentum % | 0.1 | |||||
| 12-1 Month Momentum % | -47.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.03 | |||||
| Quick Ratio | 0.03 | |||||
| Days Inventory | 238.8 | |||||
| Days Sales Outstanding | 69.43 | |||||
| Days Payable | 16798.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -54.2 | |||||
| Shareholder Yield % | -2676.58 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.94 | |||||
| Operating Margin % | -6719.57 | |||||
| Net Margin % | -9028.8 | |||||
| FCF Margin % | -2032.07 | |||||
| ROA % | -67.37 | |||||
| ROIC % | -24.31 | |||||
| 3-Year ROIIC % | 451.51 | |||||
| ROC (Joel Greenblatt) % | -565.26 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.7 | |||||
| EV-to-EBIT | -4.86 | |||||
| EV-to-EBITDA | -5.72 | |||||
| EV-to-Revenue | 150.34 | |||||
| EV-to-FCF | -7.22 | |||||
| Price-to-GF-Value | 0.12 | |||||
| Earnings Yield (Greenblatt) % | -20.58 | |||||
| FCF Yield % | -350.09 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MRZM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Marizyme Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.184 | ||
| EPS (TTM) ($) | -0.11 | ||
| Beta | 0.21 | ||
| 3-Year Sharpe Ratio | 0.2 | ||
| 3-Year Sortino Ratio | 0.72 | ||
| Volatility % | 530.5 | ||
| 14-Day RSI | 22.1 | ||
| 14-Day ATR ($) | 0.010072 | ||
| 20-Day SMA ($) | 0.02479 | ||
| 12-1 Month Momentum % | -47.37 | ||
| 52-Week Range ($) | 0.0017 - 0.1195 | ||
| Shares Outstanding (Mil) | 131.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Marizyme Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Marizyme Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Marizyme Inc Frequently Asked Questions
What is Marizyme Inc(MRZM)'s stock price today?
The current price of MRZM is $0.01. The 52 week high of MRZM is $0.12 and 52 week low is $0.00.
When is next earnings date of Marizyme Inc(MRZM)?
The next earnings date of Marizyme Inc(MRZM) is 2025-05-28 Est..
Does Marizyme Inc(MRZM) pay dividends? If so, how much?
Marizyme Inc(MRZM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers